PDA

View Full Version : Opium crops spread in Afghanistan as Taliban gains ground, U.N. says




AngryCanadian
10-23-2016, 08:53 AM
Another Obama's/Hillary failed legacy. (Opium crops spread in Afghanistan as Taliban gains ground, U.N. says)



The cultivation of opium poppy in Afghanistan, the world's main source of heroin, has risen to its third-highest level in more than 20 years, the United Nations confirmed on Sunday, as the Taliban insurgency gains ground.


"Eradication has dropped precipitously to 355 hectares — a fall of some 91 percent," Fedotov said. The report said cultivation was also spreading to new areas, as the number of poppy-free provinces fell to 13 from 14 out of a total of 34.

tod evans
10-23-2016, 09:27 AM
Opium isn't bad, US drug laws are.

enhanced_deficit
10-23-2016, 09:51 AM
After 13 years of Obama's "good war" in which tens of thousands of Americans lives/limbs were lost, Talibans are taking control ?
Or many of these crops are being raised by US tax payers funded war lords who are supposed to our friends but actualy could be supporting "insider attacks" against US?

It can't be an accident that opium crops have expanded under US occupation.


Related

The 12-Year War: 73% of U.S. Casualties in Afghanistan on Obama's Watch (http://www.ronpaulforums.com/showthread.php?427493-The-12-Year-War-73-of-U-S-Casualties-in-Afghanistan-on-Obama-s-Watch&)

Zippyjuan
10-23-2016, 12:43 PM
There are only two ways to actually make money there- either getting paid as a soldier or growing poppies. Which would you prefer they do? Should we send military over to enforce either of them on Afghanistan? (Russia had problems with opium addiction since their "adventures in Afghanistan" too. )

Why Russia is concerned about Afghanistan opium production: http://www.bloomberg.com/news/articles/2014-11-14/afghan-opium-crop-inflames-u-s-tensions-with-russia


Why Putin Might Blame the U.S. for Russia’s Drugs Problem

Another record poppy crop in Afghanistan, already the source of 90 percent of the world’s heroin, threatens to exacerbate the drug problem in Russia and stoke tensions between President Vladimir Putin and the U.S.

As the biggest market for illicit opiates, Russia is in the front line as the U.S. withdraws its troops from Afghanistan after spending an estimated $7.6 billion in a failed attempt to curb narcotics production.

Russia now faces a public health crisis and a rise in crime stoked by the flow of Afghan heroin, Yuri Fedotov, executive secretary of the United Nations Office on Drugs and Crime, said Nov. 12 at a briefing in Vienna. The U.S. special inspector general for Afghanistan reconstruction, John Sopko, visited Fedotov this week to give his assessment of the lost drug war.

“This failure in Afghanistan affects what I call the new Cold War with Russia,” said Robert Legvold, who led an effort by the American Academy of Arts and Sciences to reformulate U.S. policy on Russia. “It supports the views expressed by Putin and his circle that U.S. foreign policy has been intentionally destructive.”

As the U.S. grapples with Russia’s encroachment in Ukraine, government officials and advisers say the failure of the Afghan drugs effort helps explain Russian sensitivities. While U.S. forces withdraw from a 13-year Afghan war that cost 2,350 American lives, more than 7,000 Russians die annually from heroin overdoses.

Police Growing Poppies

Russians, who already account for about a fifth of the $70 billion global opiate market, are unlikely to see a reduction of supply in the foreseeable future, according to the UN. A reduced North Atlantic Treaty Organization presence in Afghanistan may encourage more poppy cultivation.

“With their departure, many jobs will be lost, so that could be one incentive to increase cultivation of opium,” said Fedotov, a former Russian diplomat. Delayed government salaries have already forced people to abandon jobs like law enforcement for poppy cultivation, he said.

Afghan land under poppy cultivation hit a record 224,000 hectares (554,000 acres) last year, according to the UN. Opium production rose about 17 percent to 6,400 tons while the number of fields eradicated by security forces plummeted 63 percent to 2,692 hectares.

Underlining the U.S. counter narcotics failure, opium production rose faster in the areas where the U.S. and U.K. targeted $56 million of aid to help farmers switch from growing poppies to pomegranates than it did in areas that received no money, the UN said.
G-8 Statement

Still, policy makers in Washington are now asking themselves whether reducing involvement in the Afghan counter narcotics fight may actually improve the situation, according to two U.S. government analysts who asked not to be named because the debates are private. Without U.S. funds that can be diverted for corruption, the Afghan traffickers may face financial constraints, they said.

This year’s increase in opium production followed a June 2013 call for efforts to curb production made by the Group of Eight leaders at their summit in Northern Ireland. Before Russia was kicked out of the group for its Ukraine land grab, it joined in on a communique urging “further measures to reduce” poppy cultivation and “tackle more effectively” Afghanistan’s drug problem.

Afghan Dependence

Countries shouldn’t expect Afghanistan to kick its habit anytime soon, according to Pakistan’s former central bank governor, Shamshad Akhtar, who now leads a UN office promoting economic development in Asia.

“Afghanistan has a dependence on one product,” Akhtar said in an interview in Vienna, where she was attending a UN meeting convened to help landlocked countries like Afghanistan diversify their economies. “The switch from one product to multiple products is not an easy one, especially in a situation where you have one very high-return product.”



If US leaves, will Russia go back in again?


With the U.S. cutting the number of troops deployed to Afghanistan by more than half before next year -- to only 9,800 in a country the size of Texas -- Russia may reassert its presence in the region, according to Ross Eventon, an analyst at the Global Drug Policy Observatory based in Swansea, U.K.